The Board in its meeting held on May 06, 2025 have considered and approved Audited Financial Results for quarter and year ended March 31, 2025.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Naperol Investments (formerly National Peroxide) filed its audited FY25 results on May 6, 2025, with auditor Kalyaniwalla & Mistry LLP issuing an Unmodified Opinion. Total income jumped sharply to ₹2,013.92 lakhs (FY24: ₹192.04 lakhs), but this was almost entirely driven by 'substantial unusual dividends' from group companies, as the company holds more than 50% of its assets in financial investments. Profit after tax actually dipped to ₹980.70 lakhs from ₹1,055.43 lakhs in FY24, while Q4FY25 was loss-making with a PBT of ₹(34.16) lakhs and PAT of ₹(25.77) lakhs. The company also started a new 'Trading Business' segment during the year and paid ₹18.71 lakhs as a SEBI settlement fee in connection with its role as a promoter of Bombay Burmah Trading Corporation. It qualifies as an Unregistered Core Investment Company. Parikh & Associates was appointed as Secretarial Auditor for 5 years (FY26–FY30), subject to shareholder approval.
The headline revenue surge is misleading — it comes from one-off dividend income, not recurring operations, and profitability actually declined slightly with a Q4 loss. For shareholders, this is essentially an investment holding company with a small new trading leg; the underlying business remains modest. The SEBI settlement fee and the trading segment are incremental items to watch, but core earnings quality has not materially improved.